E.g., 10/29/2020
E.g., 10/29/2020
Title Credit Type Specialtysort descending Event date
Antithrombotic Therapy in PAD: From Acute to Chronic Care
Online Presentation

The goal of this activity is to increase knowledge on the latest clinical data for the use of factor Xa inhibitor therapy in patients with peripheral artery disease (PAD) and to increase competence for use of antithrombotic therapy in patients with PAD who have undergone recent peripheral revascularization.
    • 0.25 AMA PRA Category 1 Credit™ credits
    • 0.25 Participation credits
Enduring Internal Medicine Ongoing
Role of SGLT2 Inhibitors in the Nephrology Practice
Online Presentation

The goal of this activity is to increase knowledge about the mechanism of action by which sodium–glucose cotransporter 2 (SGLT2) inhibitors can impact renal outcomes and to have greater competence in treating diabetic kidney disease in safe and effective ways.
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
Enduring Internal Medicine Ongoing
Episode 5: DOACs and VTE Prevention in Acutely Ill Medical Patients: Implications on Arterial Events
Online Presentation

The goal of this activity is to provide the latest information on the effects of direct oral anticoagulants (DOACs) on both arterial and venous thromboembolic events and how this impacts patient morbidity and mortality.
    • 0.25 AMA PRA Category 1 Credit™ credits
    • 0.25 Participation credits
    • 0.25 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing
Digging Deep in Data: Comparing Renal Outcomes From Trials on SGLT2 Inhibitors
Online Presentation

The goal of this activity is to improve awareness of data on the renoprotective effects of SGLT2 inhibitors in people with type 2 diabetes (T2D).
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
Enduring Internal Medicine Ongoing
Faculty Advancing Medical Education (FAME): Using Social Media to Advance Your Mission (From Programs to Passion)
Online Webinar

Faculty Advancing in Medical Education (FAME) supports faculty educators by providing resources and training in key conceptual and practical skills in teaching and assessment.
    • 1.00 AMA PRA Category 1 Credit™ credit
    • 1.00 Participation credit
Live Internal Medicine Thursday, September 24, 2020 - 12:00pm to 1:00pm
Advances in HIV/AIDS: How to Improve Patient Satisfaction and Outcomes
Webconference

This activity is intended for health professionals involved in the treatment and management of HIV.
    • 1.00 AMA PRA Category 1 Credit™ credit
    • 1.00 Participation credit
Live Internal Medicine Friday, August 14, 2020 - 12:00pm to 1:00pm
Episode 1: VTE Risk Assessment in Medically Ill Patients: What Does the Latest Evidence Suggest?
Online Presentation

The goal of this activity is to review the use of venous thromboembolism (VTE) risk stratification strategies in medically-ill hospitalized patients.
    • 0.25 AMA PRA Category 1 Credit™ credits
    • 0.25 Participation credits
    • 0.25 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing
Antithrombotic Therapy in Patients With Polyvascular Disease: Practice Your Skills
Online Interactive Simulation

The goal of this activity is to utilize evidence-based strategies for the assessment and diagnosis of polyvascular disease and to provide comprehensive management for patients requiring antithrombotic therapy.
    • 1.00 AMA PRA Category 1 Credit™ credit
    • 1.00 Participation credit
    • 1.00 Nursing Contact Hours credit
Enduring Internal Medicine Ongoing
Faculty Advancing Medical Education (FAME): Zoom Zoom...Revving Up Your e-Learning
Online Webinar

Faculty Advancing in Medical Education (FAME) supports faculty educators by providing resources and training in key conceptual and practical skills in teaching and assessment.
    • 1.00 AMA PRA Category 1 Credit™ credit
    • 1.00 Participation credit
Live Internal Medicine Friday, December 11, 2020 - 12:00pm to 1:00pm
What’s New in PAD: Factor Xa Inhibitors and Antiplatelet Postprocedure
Online Presentation

The goals of this activity are to inform participants about the latest clinical data regarding factor Xa inhibitor therapy in patients with peripheral artery disease (PAD) and to improve the use of antithrombotic therapy in patients with PAD who have undergone recent peripheral revascularization.
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
Enduring Internal Medicine Ongoing
Managing Complicated Patients with T2D
Online Interactive Simulation

The goal of this activity is to utilize evidence-based strategies for the assessment and diagnosis of polyvascular disease and to provide comprehensive management for patients requiring antithrombotic therapy.
    • 1.00 AMA PRA Category 1 Credit™ credit
    • 1.00 Participation credit
Enduring Internal Medicine Ongoing
Risk Stratification in CAD and PAD: Evaluating the Latest Evidence
Online Presentation

The goal of this activity is to provide an update on the use of antithrombotic agents in appropriate patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD).
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
    • 0.50 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing
Episode 6: VTE Prevention in the Hospital: Who, How, and When?
Online Presentation

The goal of this activity is to provide the latest information on the prevention of venous thromboembolism (VTE) in hospitalized medically ill patients.
    • 0.25 AMA PRA Category 1 Credit™ credits
    • 0.25 Participation credits
    • 0.25 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing
Factor Xa Inhibitors in CAD and Diabetes: Evaluating the Latest Data
Online Presentation

The goal of this activity is to learn about the latest clinical trial data on the use of combination anticoagulant and antiplatelet therapy in patients with CAD and diabetes.
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
    • 0.50 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing
Preventing Death in T2D and DKD Patients: What Is the Primary Target of Treatment?
Online Presentation

The goal of this activity is to improve awareness of new strategies to prevent cardiovascular (CV) events in people who have diabetic kidney disease (DKD) in type 2 diabetes (T2D).
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
    • 0.50 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing

Pages